C1orf173 | Chromosome 1 open reading frame 173 | | | | | | Group enriched |
CACNA1B | Calcium channel, voltage-dependent, N type, alpha 1B subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
CHD5 | Chromodomain helicase DNA binding protein 5 | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
CNDP1 | Carnosine dipeptidase 1 (metallopeptidase M20 family) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CSMD3 | CUB and Sushi multiple domains 3 | Predicted membrane proteins
| | | | | Group enriched |
CTNNA2 | Catenin (cadherin-associated protein), alpha 2 | Plasma proteins
| | | | | Group enriched |
DACH2 | Dachshund homolog 2 (Drosophila) | | | | | | Group enriched |
DOC2A | Double C2-like domains, alpha | | | | | | Group enriched |
ELOVL2 | ELOVL fatty acid elongase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ETNPPL | Ethanolamine-phosphate phospho-lyase | Enzymes Mitochondrial proteins
| | | | | Group enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
FRRS1L | Ferric-chelate reductase 1-like | Predicted membrane proteins
| | | | | Group enriched |
GALNT9 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) | Enzymes Predicted membrane proteins
| | | | | Group enriched |
GRM2 | Glutamate receptor, metabotropic 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ICAM5 | Intercellular adhesion molecule 5, telencephalin | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes
| | | | | Group enriched |
LPPR5 | Lipid phosphate phosphatase-related protein type 5 | Predicted membrane proteins
| | | | | Group enriched |
MAG | Myelin associated glycoprotein | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MC4R | Melanocortin 4 receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MPPED1 | Metallophosphoesterase domain containing 1 | Predicted secreted proteins
| | | | | Group enriched |
MYT1 | Myelin transcription factor 1 | Plasma proteins Transcription factors
| | | | | Group enriched |
NGB | Neuroglobin | | | | | | Group enriched |
RALYL | RALY RNA binding protein-like | | | | | | Group enriched |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes
| | | | | Group enriched |
SPOCK3 | Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 | Predicted secreted proteins
| | | | | Group enriched |
SRSF12 | Serine/arginine-rich splicing factor 12 | | | | | | Group enriched |
UNC13C | Unc-13 homolog C (C. elegans) | | | | | | Group enriched |
ZNF365 | Zinc finger protein 365 | Disease related genes
| | | | | Group enriched |
ADARB2 | Adenosine deaminase, RNA-specific, B2 (non-functional) | | | | | | Group enriched |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted membrane proteins
| | | | | Group enriched |
AMH | Anti-Mullerian hormone | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP8A2 | ATPase, aminophospholipid transporter, class I, type 8A, member 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
C2CD4C | C2 calcium-dependent domain containing 4C | | | | | | Group enriched |
CADM3 | Cell adhesion molecule 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CAMK2B | Calcium/calmodulin-dependent protein kinase II beta | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CARNS1 | Carnosine synthase 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CDR1 | Cerebellar degeneration-related protein 1, 34kDa | | | | | | Group enriched |
CECR6 | Cat eye syndrome chromosome region, candidate 6 | Predicted membrane proteins
| | | | | Group enriched |
CELF3 | CUGBP, Elav-like family member 3 | | | | | | Group enriched |
CERS1 | Ceramide synthase 1 | Predicted membrane proteins
| | | | | Group enriched |
CRB1 | Crumbs homolog 1 (Drosophila) | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CXXC11 | CXXC finger protein 11 | Predicted membrane proteins
| | | | | Group enriched |
DCX | Doublecortin | Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
DDN | Dendrin | | | | | | Group enriched |
DIRAS1 | DIRAS family, GTP-binding RAS-like 1 | | | | | | Group enriched |
DNER | Delta/notch-like EGF repeat containing | Cancer-related genes Predicted membrane proteins
| | | | | Group enriched |
DPYSL5 | Dihydropyrimidinase-like 5 | Plasma proteins
| | | | | Group enriched |
ELAVL4 | ELAV like neuron-specific RNA binding protein 4 | | | | | | Group enriched |
ERBB4 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |